Best Agrolife H1 EBITDA rises 45% despite revenue decline

Best Agrolife Limited reported higher first-half earnings despite lower sales in H1FY27. Revenue from operations declined 11% year on year to Rs 803 crore for the six months ended September 30, 2026, while EBITDA rose 45% to Rs 178 crore and profit after tax increased 67% to Rs 98 crore, expanding operating and net margins.

How did Best Agrolife perform in H1FY27?

Best Agrolife recorded revenue from operations of Rs 803 crore in H1FY27, down 11% year on year, while EBITDA increased 45% to Rs 178 crore and PAT rose 67% to Rs 98 crore. The company attributed the sales decline to irregular monsoon rainfall, delayed sowing, lower crop-protection demand in certain markets and heightened competition during the Kharif season.

The six-month margin data shows the change in earnings conversion. EBITDA margin increased to 22% in H1FY27 from 14% in H1FY26, while PAT margin rose to 12% from 7%. EBITDA means earnings before interest, tax, depreciation and amortisation, and PAT means profit after tax.

Best Agrolife said operating expenses excluding finance costs and depreciation declined 5% year on year in H1FY27. The reported H1FY27 figures therefore show revenue falling while EBITDA and PAT increased, with management citing expense discipline, operational efficiency and its product mix as contributors.

What changed for Best Agrolife in Q2FY27?

Best Agrolife reported Q2FY27 revenue from operations of Rs 407 crore, down 21% year on year, while EBITDA rose 30% to Rs 101 crore and PAT increased 48% to Rs 57 crore. The quarterly revenue decline was larger than the 11% H1FY27 reduction reported for the six months ended September 30, 2026.

Q2FY27 EBITDA margin was 25%, compared with 15% in Q2FY26, and PAT margin was 14%, compared with 8% a year earlier. Operating expenses excluding finance costs and depreciation declined 12% year on year in Q2FY27, compared with a 5% fall for H1FY27.

Managing Director Vimal Kumar described Q2FY27 as challenging for the domestic crop-protection industry. He said irregular rainfall delayed and made sowing uneven, while moisture stress and limited irrigation affected crop establishment and the timing of crop-protection applications; cautious farmer spending and competition added to the pressure.

Why did Best Agrolife’s margins rise as revenue fell?

Best Agrolife said a strategic shift over the past two years towards a stronger patented-product portfolio was an important contributor to margin expansion. Management also cited cost discipline and operational efficiency, alongside the 12% decline in relevant operating expenses in Q2FY27 and the 5% decline in H1FY27.

The company said it made a higher provision for sales returns in anticipation of the irregular monsoon's impact. Kumar said the sales-return percentage declined during the year, with H1FY27 sales returns lower than H1FY26 sales returns, although the announcement did not disclose either percentage or the provision amount.

The reported margins quantify the difference between sales and profitability. H1FY27 EBITDA margin increased by 8 percentage points to 22%, while PAT margin increased by 5 percentage points to 12%; in Q2FY27, the respective increases were 10 percentage points and 6 percentage points. Best Agrolife did not provide a numerical allocation of the improvement among patented products, expenses and sales returns.

What product and overseas developments did Best Agrolife report?

Best Agrolife secured a patent grant during the period for a combination of Fluxametamide, Abamectin and Trifloxystrobin. Kumar said management intends to further strengthen the patented portfolio, with innovation and intellectual property forming part of its long-term growth strategy.

Best Agrolife also reported a 47-metric-tonne shipment to Sudan, registration of its patented Ronfen product in Nepal and registration of Lambda technical in Mexico. Four additional products had been submitted for registration in Nepal, but the announcement gave no revenue, profit or timing forecast for these international activities.

The company described itself as a research-and-development-based Indian agrochemical business engaged in developing, manufacturing and marketing crop-protection solutions. The disclosed actions for the period ended September 30, 2026 combined a new patent, one Sudan shipment and product-registration activity in Nepal and Mexico rather than a geographic revenue breakdown.

What reporting matter remains unresolved for Best Agrolife?

Best Agrolife's standalone unaudited results for the quarter and six months ended September 30, 2026 were reviewed by Walker Chandiok & Co LLP under Indian Accounting Standard 34, Interim Financial Reporting. The auditor said nothing had come to its attention suggesting that the statement lacked required disclosures or contained a material misstatement, while noting that a review has a narrower scope than an audit.

The auditor drew attention to an Income Tax Department search and seizure operation during the year ended March 31, 2024, covering Best Agrolife's head office, other company and subsidiary premises, and residences of certain key managerial persons. The company received a demand order for assessment year 2021-22 in the previous year and reassessment notices for assessment years 2018-19 through 2020-21.

Walker Chandiok said the effect of this matter on the financial statements for the period from April 1, 2026 to September 30, 2026, and any required adjustments, was not ascertainable. Its review conclusion was not modified in respect of the matter, leaving the financial effect unresolved alongside H1FY27 PAT of Rs 98 crore.

Conclusion

Best Agrolife reported a divergence between sales and earnings in H1FY27: revenue from operations fell 11% to Rs 803 crore, while EBITDA rose 45% to Rs 178 crore and PAT increased 67% to Rs 98 crore. The disclosed margin expansion coincided with lower relevant operating expenses, a patented-product portfolio shift cited by management and lower sales returns than in H1FY26.

The next domestic variable is the progress of Rabi sowing, which management said will shape the second-half FY27 outlook. Best Agrolife plans to strengthen domestic execution and its patented portfolio while pursuing international opportunities, including four product registrations submitted in Nepal; the tax matter identified by the auditor also remains unresolved.